2020
DOI: 10.1177/1078155220960222
|View full text |Cite
|
Sign up to set email alerts
|

Leveraging advanced preparation of oncology medications: Decreasing turnaround-times in an outpatient infusion center

Abstract: Introduction Many oncology infusions are provided in hospital-based infusion centers. With hospital-based infusion centers seeing increased volumes, patient wait times continue to be a priority. Extended wait times for oncology infusions have been shown to lead to patient dissatisfaction. Methods Advanced Preparation of oncology infusion medications allows pharmacy to verify and prepare specific medications the day before a patient’s infusion appointment. Our study targeted lower cost, commonly used medication… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 9 publications
0
2
0
Order By: Relevance
“…Considering the complexity of cancer management, with more and more available treatments, often with several drugs combined, it has become a priority for hospitals to be able to reduce patient waiting times, both for operational needs and patient comfort. 33 Advanced prescription and therefore advanced production are both potential levers for achieving these objectives, 23,34,35 but not without risks. 17 One of the most widely used risk analysis tools is Failure Mode, Effects and Criticality Analysis (FMECA), which assesses processes to identify risks and promote corrective measures.…”
Section: Discussionmentioning
confidence: 99%
“…Considering the complexity of cancer management, with more and more available treatments, often with several drugs combined, it has become a priority for hospitals to be able to reduce patient waiting times, both for operational needs and patient comfort. 33 Advanced prescription and therefore advanced production are both potential levers for achieving these objectives, 23,34,35 but not without risks. 17 One of the most widely used risk analysis tools is Failure Mode, Effects and Criticality Analysis (FMECA), which assesses processes to identify risks and promote corrective measures.…”
Section: Discussionmentioning
confidence: 99%
“…The reported waste in an advanced preparation program varies between available literature (0–21.7%) while some sites selected lower cost medications to minimize financial impact of waste; while cost formulas were not explicitly defined in available studies. 15,19,54 In our study, there are a number of strategies that sites have taken to minimize waste including: obtaining labs in advance, requiring patient received therapy previously, patient screening for reliability, and check-in calls prior to therapy. The frequency which these strategies were deployed was variable across sites (Table 13).…”
Section: Discussionmentioning
confidence: 99%